202 related articles for article (PubMed ID: 27529688)
1. Long-Term Non-End-Stage Renal Disease Risks After Living Kidney Donation.
Matas AJ; Hays RE; Ibrahim HN
Am J Transplant; 2017 Apr; 17(4):893-900. PubMed ID: 27529688
[TBL] [Abstract][Full Text] [Related]
2. Mid- and Long-Term Health Risks in Living Kidney Donors: A Systematic Review and Meta-analysis.
O'Keeffe LM; Ramond A; Oliver-Williams C; Willeit P; Paige E; Trotter P; Evans J; Wadström J; Nicholson M; Collett D; Di Angelantonio E
Ann Intern Med; 2018 Feb; 168(4):276-284. PubMed ID: 29379948
[TBL] [Abstract][Full Text] [Related]
3. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
[TBL] [Abstract][Full Text] [Related]
4. GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.
Matas AJ; Vock DM; Ibrahim HN
Am J Transplant; 2018 Mar; 18(3):625-631. PubMed ID: 28980397
[TBL] [Abstract][Full Text] [Related]
5. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
6. Estimating risks of de novo kidney diseases after living kidney donation.
Steiner RW; Ix JH; Rifkin DE; Gert B
Am J Transplant; 2014 Mar; 14(3):538-44. PubMed ID: 24612746
[TBL] [Abstract][Full Text] [Related]
7. Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.
Muzaale AD; Massie AB; Anjum S; Liao C; Garg AX; Lentine KL; Segev DL
Am J Transplant; 2016 Dec; 16(12):3532-3539. PubMed ID: 27172445
[TBL] [Abstract][Full Text] [Related]
8. Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
Anjum S; Muzaale AD; Massie AB; Bae S; Luo X; Grams ME; Lentine KL; Garg AX; Segev DL
Am J Transplant; 2016 Dec; 16(12):3540-3547. PubMed ID: 27287605
[TBL] [Abstract][Full Text] [Related]
9. Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.
Lentine KL; Lam NN; Segev DL
Clin J Am Soc Nephrol; 2019 Apr; 14(4):597-608. PubMed ID: 30858158
[TBL] [Abstract][Full Text] [Related]
10. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group.
Maggiore U; Budde K; Heemann U; Hilbrands L; Oberbauer R; Oniscu GC; Pascual J; Schwartz Sorensen S; Viklicky O; Abramowicz D;
Nephrol Dial Transplant; 2017 Feb; 32(2):216-223. PubMed ID: 28186535
[TBL] [Abstract][Full Text] [Related]
11. Patterns and predictors of fatigue following living donor nephrectomy: Findings from the KDOC Study.
Rodrigue JR; Fleishman A; Schold JD; Morrissey P; Whiting J; Vella J; Kayler LK; Katz DA; Jones J; Kaplan B; Pavlakis M; Mandelbrot DA;
Am J Transplant; 2020 Jan; 20(1):181-189. PubMed ID: 31265199
[TBL] [Abstract][Full Text] [Related]
12. Causes and timing of end-stage renal disease after living kidney donation.
Matas AJ; Berglund DM; Vock DM; Ibrahim HN
Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
[TBL] [Abstract][Full Text] [Related]
13. Hypertension after kidney donation: Incidence, predictors, and correlates.
Sanchez OA; Ferrara LK; Rein S; Berglund D; Matas AJ; Ibrahim HN
Am J Transplant; 2018 Oct; 18(10):2534-2543. PubMed ID: 29498216
[TBL] [Abstract][Full Text] [Related]
14. Weight gain after kidney donation: Association with increased risks of type 2 diabetes and hypertension.
Issa N; Sánchez OA; Kukla A; Riad SM; Berglund DM; Ibrahim HN; Matas AJ
Clin Transplant; 2018 Sep; 32(9):e13360. PubMed ID: 30053320
[TBL] [Abstract][Full Text] [Related]
15. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
[TBL] [Abstract][Full Text] [Related]
16. The true risk of living kidney donation.
Liyanage L; Muzaale A; Henderson M
Curr Opin Organ Transplant; 2019 Aug; 24(4):424-428. PubMed ID: 31145155
[TBL] [Abstract][Full Text] [Related]
17. Examining post-donation outcomes in Hispanic/Latinx living kidney donors in the United States: A systematic review.
Alvarado F; Cervantes CE; Crews DC; Blanck J; Al Ammary F; Ng DK; Purnell TS
Am J Transplant; 2022 Jul; 22(7):1737-1753. PubMed ID: 35258164
[TBL] [Abstract][Full Text] [Related]
18. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
19. Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.
Lim HJ; Jambaldorj E; Lee Y; Kang SS; Koo TY; Ahn C; Yang J
Transplant Proc; 2016 Sep; 48(7):2407-2411. PubMed ID: 27742310
[TBL] [Abstract][Full Text] [Related]
20. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
Vock DM; Helgeson ES; Mullan AF; Issa NS; Sanka S; Saiki AC; Mathson K; Chamberlain AM; Rule AD; Matas AJ
BMC Nephrol; 2023 May; 24(1):121. PubMed ID: 37127560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
